2024
DOI: 10.1016/j.ejca.2024.113984
|View full text |Cite
|
Sign up to set email alerts
|

The RANKL inhibitor denosumab in combination with dual checkpoint inhibition is associated with increased CXCL-13 serum concentrations

Katrin Schaper-Gerhardt,
Ralf Gutzmer,
Yenny Angela
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 31 publications
0
0
0
Order By: Relevance